Efficacy and Safety of Tapentadol ER for Diabetic Peripheral Neuropathic Pain: Results of a Randomized-Withdrawal, Double-Blind, Placebo-Controlled Phase III Study

被引：0
|
作者：
Etropolski, Mila
Shapiro, Douglas
Okamoto, Akiko
Rauschkolb-Loeffler, Christine
Haeussler, Juergen
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A217 / A218
页数：2
相关论文
共 50 条
  • [41] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [42] BARICITINIB IN JUVENILE IDIOPATHIC ARTHRITIS: A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, WITHDRAWAL, EFFICACY AND SAFETY STUDY
    Ramanan, A.
    Quartier, P.
    Okamoto, N.
    Meszaros, G.
    Araujo, J.
    Wang, Z.
    Liao, R.
    Crowe, B.
    Zhang, X.
    Decker, R.
    Keller, S.
    Brunner, H.
    Ruperto, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 207 - 208
  • [43] Baricitinib in Juvenile Idiopathic Arthritis: A Phase 3, Double-Blind, Placebo-Controlled, Withdrawal, Efficacy and Safety Study
    Ramanan, Athimalaipet
    Maire, Pierre Quartier Dit
    Okamoto, Nami
    Meszaros, Gabriella
    Araujo, Joana
    Wang, Zhongkai
    Liao, Ran
    Crowe, Brenda
    Zhang, Xin
    Decker, Rodney
    Keller, Stuart
    Brunner, Hermine
    Ruperto, Nicola
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4385 - 4387
  • [44] Treatment of Excessive Sleepiness in Patients With OSA: Efficacy and Safety Results of a 6-Week, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Trial of JZP-110
    Strollo, Patrick
    Redline, Susan
    Hedner, Jan
    Collop, Nancy
    Lorch, Daniel
    Chen, Dan
    Li, Joan
    Carter, Lawrence
    Lee, Lawrence
    Black, Jed
    Pepin, Jean Louis
    CHEST, 2017, 152 (04) : 1092A - 1093A
  • [45] The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial
    Dakin, Paula
    DiMartino, Stephen J.
    Gao, Haitao
    Maloney, Jennifer
    Kivitz, Alan J.
    Schnitzer, Thomas J.
    Stahl, Neil
    Yancopoulos, George D.
    Geba, Gregory P.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (11) : 1824 - 1834
  • [46] Analgesic Efficacy of Fulranumab in Patients with Painful Diabetic Peripheral Neuropathy in a Randomized, Placebo-Controlled, Double-Blind Study
    Wang, Hao
    Romano, Gary
    Frustaci, Mary Ellen
    Sanga, Panna
    Ness, Seth
    Russell, Lucille
    Fedgchin, Margaret
    Kelly, Kathleen
    Thipphawong, John
    NEUROLOGY, 2013, 80
  • [47] A PHASE III, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF NEUCARDIN™ IN PATIENTS WITH CHRONIC HEART FAILURE
    Gao, Runlin
    Zhang, Jian
    Liu, Heping
    Wang, Lina
    Pang, Xiaohua
    Fu, Lu
    Meng, Fanbo
    Zhou, Mingdong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 668 - 668
  • [48] A Comparative Efficacy of Amitriptyline, Gabapentin, and Pregabalin in Neuropathic Cancer Pain: A Prospective Randomized Double-Blind Placebo-Controlled Study
    Mishra, Seema
    Bhatnagar, Sushma
    Goyal, Gaurav Nirvani
    Rana, Shiv Pratap Singh
    Upadhya, Surjya Prasad
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2012, 29 (03): : 177 - 182
  • [49] A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
    Tandon, R.
    Loebel, A.
    Phillips, D.
    Pikalov, A.
    Hernandez, D.
    Mao, Y.
    Cucchiaro, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 153 - 154
  • [50] A Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of Lisdexamfetamine Dimesylate in Adults with Moderate to Severe Binge Eating Disorder
    Hudson, James
    McElroy, Susan
    Ferreira-Cornwell, Celeste
    Radewonuk, Jana
    Gasior, Maria
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S135 - S136
12345